Cadence Pharmaceuticals
AcquiredSan Diego, United States · Founded 2004 · $86.6M raised
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2004
- Business Model
- B2B
- Website
- cadencepharm.com
- Total Funding
- $86.6M
- Last Round
- $86.6M Series AFeb 2009
- Rounds
- 1
- Acquisition Date
- Feb 2014
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.
About
Cadence Pharmaceuticals was a San Diego-based specialty pharmaceutical company focused on developing and commercializing products for use in the hospital setting, primarily targeting acute pain management. The company's lead product was Ofirmev (IV acetaminophen). Cadence raised approximately $197 million in funding before being acquired by Mallinckrodt PLC in 2014 for approximately $1.3 billion.
Summary
Cadence Pharmaceuticals is a Biotech company based in San Diego, United States, founded in 2004. It has raised $86.6M in total across 1 round, most recently a $86.6M Series A round in Feb 2009. Investors include Venrock, Frazier Healthcare and Domain Associates.
Funding & Exit History
Feb 2014
Sign up to see all 3 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cadence-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/cadence-pharmaceuticals" alt="Cadence Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>